It was similar to the results of Galvano et al. [27], who had proved that PAF could play a critical role in thrombosis, acute inflammation, anaphylactic shock, and other symptoms, indicating that the UK-LSA-CHT group was more effective in the treatment of deep vein thrombosis than other groups. The gene discussed is SLC5A7; the disease is deep vein thrombosis.